Cargando…
Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation
Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker e...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929991/ https://www.ncbi.nlm.nih.gov/pubmed/31903159 http://dx.doi.org/10.7150/thno.35045 |
_version_ | 1783482808899993600 |
---|---|
author | Lo Re, Oriana Mazza, Tommaso Giallongo, Sebastiano Sanna, Paola Rappa, Francesca Vinh Luong, Tu Li Volti, Giovanni Drovakova, Adela Roskams, Tania Van Haele, Matthias Tsochatzis, Emmanuel Vinciguerra, Manlio |
author_facet | Lo Re, Oriana Mazza, Tommaso Giallongo, Sebastiano Sanna, Paola Rappa, Francesca Vinh Luong, Tu Li Volti, Giovanni Drovakova, Adela Roskams, Tania Van Haele, Matthias Tsochatzis, Emmanuel Vinciguerra, Manlio |
author_sort | Lo Re, Oriana |
collection | PubMed |
description | Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses. Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental HCC cells activated regulatory CD4(+)/CD25(+)/FoxP3(+) T cells (Tregs). Conclusions: Loss of macroH2A1 in HCC cells drives cancer stem-cell propagation and evasion from immune surveillance. |
format | Online Article Text |
id | pubmed-6929991 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Ivyspring International Publisher |
record_format | MEDLINE/PubMed |
spelling | pubmed-69299912020-01-04 Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation Lo Re, Oriana Mazza, Tommaso Giallongo, Sebastiano Sanna, Paola Rappa, Francesca Vinh Luong, Tu Li Volti, Giovanni Drovakova, Adela Roskams, Tania Van Haele, Matthias Tsochatzis, Emmanuel Vinciguerra, Manlio Theranostics Research Paper Rationale: Loss of histone macroH2A1 induces appearance of cancer stem cells (CSCs)-like cells in hepatocellular carcinoma (HCC). How CSCs interact with the tumor microenvironment and the adaptive immune system is unclear. Methods: We screened aggressive human HCC for macroH2A1 and CD44 CSC marker expression. We also knocked down (KD) macroH2A1 in HCC cells, and performed integrated transcriptomic and secretomic analyses. Results: Human HCC showed low macroH2A1 and high CD44 expression compared to control tissues. MacroH2A1 KD CSC-like cells transferred paracrinally their chemoresistant properties to parental HCC cells. MacroH2A1 KD conditioned media transcriptionally reprogrammed parental HCC cells activated regulatory CD4(+)/CD25(+)/FoxP3(+) T cells (Tregs). Conclusions: Loss of macroH2A1 in HCC cells drives cancer stem-cell propagation and evasion from immune surveillance. Ivyspring International Publisher 2020-01-01 /pmc/articles/PMC6929991/ /pubmed/31903159 http://dx.doi.org/10.7150/thno.35045 Text en © The author(s) This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions. |
spellingShingle | Research Paper Lo Re, Oriana Mazza, Tommaso Giallongo, Sebastiano Sanna, Paola Rappa, Francesca Vinh Luong, Tu Li Volti, Giovanni Drovakova, Adela Roskams, Tania Van Haele, Matthias Tsochatzis, Emmanuel Vinciguerra, Manlio Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation |
title | Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation |
title_full | Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation |
title_fullStr | Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation |
title_full_unstemmed | Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation |
title_short | Loss of histone macroH2A1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and CD4(+)CD25(+)FoxP3(+) regulatory T cells activation |
title_sort | loss of histone macroh2a1 in hepatocellular carcinoma cells promotes paracrine-mediated chemoresistance and cd4(+)cd25(+)foxp3(+) regulatory t cells activation |
topic | Research Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6929991/ https://www.ncbi.nlm.nih.gov/pubmed/31903159 http://dx.doi.org/10.7150/thno.35045 |
work_keys_str_mv | AT loreoriana lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT mazzatommaso lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT giallongosebastiano lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT sannapaola lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT rappafrancesca lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT vinhluongtu lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT livoltigiovanni lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT drovakovaadela lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT roskamstania lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT vanhaelematthias lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT tsochatzisemmanuel lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation AT vinciguerramanlio lossofhistonemacroh2a1inhepatocellularcarcinomacellspromotesparacrinemediatedchemoresistanceandcd4cd25foxp3regulatorytcellsactivation |